Sanofi
A global biopharmaceutical company that discovers, develops, and markets medicines and vaccines.
SAN | PA
Overview
Corporate Details
- ISIN(s):
- FR0000120578 (+39 more)
- LEI:
- 549300E9PC51EN656011
- Country:
- France
- Address:
- 46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
- Sector:
- Manufacturing
Description
Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2023-07-17 19:00 |
Press Release: FDA approves Beyfortus™ (nirsevimab-alip) to protect infants aga…
|
English | PDF • 249.1 KB | ||
| 2023-07-05 14:43 |
6-K
|
English | ZIP • 45.4 KB | ||
| 2023-06-30 09:38 |
Franchissement de seuil
|
French | PDF • 263.3 KB | ||
| 2023-06-29 07:30 |
Press Release: Vaccines R&D pipeline raises the bar in RSV, influenza, meningit…
|
English | PDF • 177.9 KB | ||
| 2023-06-29 07:30 |
Communiqué de presse : Le pipeline Vaccins de Sanofi relève la barre contre le …
|
French | PDF • 159.5 KB | ||
| 2023-06-28 20:32 |
FORM 11-K
|
English | ZIP • 50.6 KB | ||
| 2023-06-28 20:31 |
FORM 11-K
|
English | ZIP • 52.4 KB | ||
| 2023-06-27 07:30 |
Communiqué de presse : Amlitelimab : De premières données positives de phase II…
|
French | PDF • 179.5 KB | ||
| 2023-06-27 07:30 |
Press Release: Positive topline Phase 2b data in atopic dermatitis support amli…
|
English | PDF • 174.3 KB | ||
| 2023-06-25 16:30 |
Communiqué : ALTUVIIIO : des données de dernière heure présentées au Congrès de…
|
French | PDF • 213.1 KB | ||
| 2023-06-25 16:30 |
Press Release: ALTUVIIIO late-breaking data at ISTH demonstrates highly effecti…
|
English | PDF • 198.0 KB | ||
| 2023-06-22 07:30 |
Press Release: Availability of the Q2 2023 Memorandum for modelling purposes
|
English | PDF • 122.1 KB | ||
| 2023-06-22 07:30 |
Communiqué de presse : Mise en ligne du document «Q2 2023 Memorandum for modell…
|
French | PDF • 140.1 KB | ||
| 2023-06-20 19:43 |
Sanofi: Information concerning the total number of voting rights and shares - M…
|
English | PDF • 142.3 KB | ||
| 2023-06-20 19:43 |
Sanofi: Informations relatives au nombre de droits de vote et d'actions - MAI 2…
|
French | PDF • 118.4 KB |
Automate Your Workflow. Get a real-time feed of all Sanofi filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sanofi
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sanofi via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-02 | N/A | Other | Buy | 71,423 | N/A |
| 2024-04-26 | N/A | Other | Buy | 1,000 | 91,380.00 EUR |
| 2023-06-09 | N/A | Other | Buy | 9 | 856.04 EUR |
| 2023-05-02 | N/A | Other | Buy | 65,205 | 6,364,008.00 EUR |
| 2023-05-02 | N/A | Other | Buy | 500 | 48,835.00 EUR |
Peer Companies
